## SIX FIGURES Thc production of hypothalamic obesity in the rat is an easy matter, requiring only that certain definite regions on both sides of the hypothalamus be destroyed. Work in this laboratory has been directed toward the identification of the precise structures, either nuclei or fiber gro
Experimental hypothalamic or genetic obesity in the non-insulin-dependent diabetic rat
✍ Scribed by B. Portha; R. Goursot; M. H. Giroix; S. Nicolaïdis; L. Picon
- Publisher
- Springer
- Year
- 1983
- Tongue
- English
- Weight
- 543 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.
✦ Synopsis
Non-insulin-dependent diabetes was obtained in adult rats by neonatal administration of streptozotocin (100 mg/kg). Obesity was obtained in the same animals either by a ventromedial hypothalamic lesion in adult non-insulin-dependent diabetic Wistar rats, or by using genetically obese Zucker rats. In diabetic rats, weight gain was similar to that in non-diabetic rats, whether hyperphagia was due to a ventromedial hypothalamic lesion or to a genetic factor. Glucose-induced insulin release in vivo was increased in obese diabetic rats compared with non-diabetic rats. Despite this enhanced insulin secretion, both diabetic 'fatty' Zucker rats and diabetic rats with hypothalamic obesity showed a deterioration of glucose tolerance. Moreover, about one-third developed overt diabetes with permanent or transient glycosuria. We conclude that when insulin-deficient rats are made hyperphagic, they are able to increase their insulin secretion and become obese. In some of these animals the occurrence of obesity aggravates the diabetes. The obese diabetic rat appears to be a suitable laboratory model for the study of the relationship between obesity and diabetes.
📜 SIMILAR VOLUMES
A study was made on the mechanism by which the consumption of peas affects beneficially the glycaemia in a rat model of non-insulin-dependent diabetes. With a standard diet, the diabetic rats showed elevated glycaemia throughout the study, varying between 8.3 and 10.0 mmol/L. With the administration